Results 191 to 200 of about 48,720 (296)

Discharge Remote Monitoring Systems for Glycemic Management After Hospital Discharge

open access: yesChronic Diseases and Translational Medicine, Volume 12, Issue 3, Page 253-259, September 2026.
Heat map of median number of telehealth interactions by subgroup and theme. Major themes identified included intervention after remote monitoring alerts (e.g., “Team reached out to participant and instructed participant to treat hypo.”), insulin dose adjustments (e.g., “Participant reported that prednisone dose is increasing … Called to discuss insulin
Nirali Shah   +14 more
wiley   +1 more source

Prospective Evaluation of Quality‐of‐Life Improvement After Dapagliflozin Initiation in a Greek Population With HFrEF: The EVOLUTION‐HF 12‐Month Results

open access: yesClinical Cardiology, Volume 49, Issue 9, September 2026.
Among patients with HFrEF, initiation of dapagliflozin resulted in significant improvements in quality of life, as demonstrated by increased KCCQ‐23 scores during follow‐up. ABSTRACT Introduction Heart failure with reduced ejection fraction (HFrEF), defined by a left ventricular ejection fraction ≤ 40%, remains a major global health challenge ...
Victoria Potoupni   +31 more
wiley   +1 more source

Type 5 Diabetes Mellitus: Pathophysiology, Clinical Phenotype, and Nutritional Management

open access: yesDiabetes/Metabolism Research and Reviews, Volume 42, Issue 6, September 2026.
ABSTRACT Type 5 Diabetes Mellitus (T5DM) is an emerging diabetes phenotype linked to chronic undernutrition. It predominantly affects young, lean individuals in low‐ and middle‐income countries. After its formal recognition by the International Diabetes Federation in 2025, T5DM resurfaced as a clinically relevant insulin‐deficient phenotype.
İrem Nur Şahin Anılgan   +1 more
wiley   +1 more source

Depression and Long‐Term HbA1c Variability Are Additively Associated With Increased Risk of Cardiovascular–Renal Outcomes, Severe Hypoglycaemia and Mortality in Type‐2 Diabetes

open access: yesDiabetes/Metabolism Research and Reviews, Volume 42, Issue 6, September 2026.
ABSTRACT Aims Depression and long‐term HbA1c variability are associated with adverse outcomes in type‐2 diabetes (T2D), which may be related to suboptimal self‐management practices and health‐related quality of life (HRQoL). Materials and Methods In the prospective Hong Kong Diabetes Register (2013–2019), we estimated the independent and joint ...
Kelly T. C. Wong   +10 more
wiley   +1 more source

No ingestion, no inhalation, still toxic: acetone poisoning via skin absorption. [PDF]

open access: yesInt J Emerg Med
Qafisheh Q   +7 more
europepmc   +1 more source

Tirzepatide and SGLT2 Inhibitors for Heart Failure With Preserved Ejection Fraction and Obesity: Entering a New Cardiometabolic Therapeutic Era

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
Tirzepatide and SGLT2 inhibitors act through distinct but complementary mechanisms in obesity‐related HFpEF: tirzepatide targets adiposity, inflammation, and insulin resistance, while SGLT2 inhibitors improve decongestion, myocardial energetics, and cardiac remodeling.
Zakariye Isak Mohamed   +8 more
wiley   +1 more source

A Systematic Review and Expert Evaluation of Perioperative SGLT2 Inhibitor-Associated Ketoacidosis Case Reports. [PDF]

open access: yesActa Anaesthesiol Scand
Snel LIP   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy